Clinical Trials Browser

Phase 2 × Craniopharyngioma × binimetinib × Clear all

NCT05286788 2026-01-12

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Phase 2 Recruiting

Craniopharyngioma